Collaboration will unlock our potential and define our success.
The Physical Therapy Excellence Fellowship supports PTs in their research or clinical projects related to the care of patients with hemophilia.
The impact of an FDA "Listening Session" on gene therapy for hemophilia.
This resource will provide much-needed guidance to emergency department personnel.
ESPEROCT® is a long-acting recombinant product for the treatment of hemophilia A.
The organizations continue to monitor the outbreak.
The new guidance issued by the FDA seeks to support both innovation and patient safety.
eNewsletter Sign Up
Steps for Living
Victory for Women
Unite for Bleeding Disorders Walk
Donate Your Car